IEX · 8-K · 20261028PR000026
Revenue Performance and Mix
IDEX CORP /DE/ · 2026-10-28 · Importance 36 · Surprise 14 · In source text
Third-quarter 2026 net sales increased 8% to $951.7 million from $878.7 million, with organic sales also up 8%. Higher volumes, primarily in Health & Science Technologies, and positive price across segments drove the increase. HST sales rose 14% to $433.5 million, Fluid & Metering Technologies sales rose 3% to $327.9 million, and Fire & Safety/Diversified Products sales rose 5% to $191.5 million.
Key facts
- IDEX third-quarter 2026 sales were a record $952 million, up 8% on both a reported and organic basis. source
- For the three months ended September 30, 2026, IDEX net sales were $951.7 million, up $73.0 million, or 8%, from $878.7 million in 2025. source
- IDEX reported diluted EPS of $1.95 and record adjusted diluted EPS of $2.33 in third-quarter 2026, each up 15%. source
- IDEX organic sales increased 8% in the third quarter of 2026. source
- IDEX third-quarter 2026 net sales increased primarily because of higher organic sales, driven by higher volumes primarily in HST and positive price across the segments. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +7.7% | For the three months ended September 30, 2026, IDEX net sales were $951.7 million, up $73.0 million, or 8%, from $878.7 million in 2025. |